Ameriprise
AUGX

Ameriprise’s Augmedix, Inc. Common Stock AUGX Stock Holding History

Ameriprise’s Portfolio AUGX Stock Details AUGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-210,531
Closed -$1.23M – 3982
2023
Q4 		$1.23M Sell
210,531
-32,099
-13% -$169K ﹤0.01% 3104
2023
Q3 		$1.25M Buy
+242,630
New +$1.14M ﹤0.01% 3044

Other funds holding AUGX

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
SM
Samjo Management New York $231M AUM 13.04% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Ameriprise's AUGX Position: Q1 2024 in Review

Ameriprise sold out of Augmedix, Inc. Common Stock (AUGX) in Q1 2024, closing a stake of 210,531 shares — an estimated $1.23M sold.

Ameriprise first reported a position in AUGX in Q3 2023 and held it in 2 quarters. The position peaked at $1.25M in Q3 2023. 84 funds tracked by Wall St. Rank hold AUGX as of Q1 2024.

  • Ameriprise reported no remaining Augmedix, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Ameriprise sold 210,531 Augmedix, Inc. Common Stock shares in Q1 2024, an estimated $1.23M.
  • Ameriprise first reported a position in Augmedix, Inc. Common Stock in Q3 2023 and held it in 2 quarters.
  • Ameriprise's Augmedix, Inc. Common Stock position peaked at $1.25M in Q3 2023.
  • 84 funds tracked by Wall St. Rank held Augmedix, Inc. Common Stock as of Q1 2024.

Based on Ameriprise's 13F filing for Q1 2024, filed 15 May 2024.